Advertisement





Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2006; 47:57-68, doi:10.1016/j.jacc.2005.11.049
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davies, J. R.
Right arrow Articles by Narula, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davies, J. R.
Right arrow Articles by Narula, J.

Radionuclide Imaging for the Detection of Inflammation in Vulnerable Plaques

John R. Davies, BSc, MBBS, MRCP*, James H.F. Rudd, PhD, MRCP{dagger}, Peter L. Weissberg, MD, FRCP*,* and Jagat Narula, MD, PhD, FACC{ddagger}

* Addenbrookes Hospital, University of Cambridge, Cambridge, United Kingdom
{dagger} Imaging Science Laboratory, Mount Sinai Hospital, New York, New York
{ddagger} University of California-Irvine School of Medicine, Irvine, California

Manuscript received June 16, 2005; revised manuscript received October 10, 2005, accepted November 16, 2005.

* Reprint requests and correspondence: Dr. Peter L. Weissberg, Division of Cardiovascular Medicine, Box 110, Level 6 ACCI, Addenbrookes Hospital, Hills Road, Cambridge CB2 2QQ, United Kingdom (Email: weissbergp{at}bhf.org.uk).

Imaging of atheromatous plaques has traditionally centered on assessing the degree of luminal stenosis. More recently it has become clear that the vulnerable atherosclerotic plaques responsible for the majority of life-threatening syndromes are characterized by high numbers of inflammatory cells and proteins. This has highlighted the urgent need for suitable imaging techniques that can identify and quantify levels of inflammation within atheromatous lesions. Positron emission tomography and single-photon emission computed tomography imaging hold promise in this regard. Tracer compounds capable of assessing macrophage recruitment, foam cell generation, matrix metalloproteinase production, macrophage apoptosis, and macrophage metabolism have been developed and tested in the carotid and peripheral circulation. The identification of inflamed lesions within the coronary circulation, however, remains elusive owing to small plaque size, cardiac and respiratory motion, and lack of a suitable specific nuclear tracer.

Abbreviations and Acronyms
  CT = computed tomography
  FDG = fluorine-18–labeled deoxyglucose
  HO-CGS 27023A = 123I-labeled molecule
  MCP-1 = monocyte chemotactic protein-1
  MDA2 = malondialdehyde-2
  MMP = matrix metalloproteinase
  MRI = magnetic resonance imaging
  oxLDL = oxidized low-density lipoprotein
  PET = positron emission tomography
  PS = phosphatidyl serine
  SPECT = single-photon emission computed tomography
  Tc = technetium
  TIA = transient ischemic attack
  WHHL = Wantanabe heritable hyperlipidemic




This article has been cited by other articles:


Home page
J Am Coll Cardiol ImgHome page
M. J. Lipinski, J. C. Frias, V. Amirbekian, K. C. Briley-Saebo, V. Mani, D. Samber, A. Abbate, J. G. S. Aguinaldo, D. Massey, V. Fuster, et al.
Macrophage-Specific Lipid-Based Nanoparticles Improve Cardiac Magnetic Resonance Detection and Characterization of Human Atherosclerosis.
J. Am. Coll. Cardiol. Img., May 1, 2009; 2(5): 637 - 647.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Calcagno, J.-C. Cornily, F. Hyafil, J. H.F. Rudd, K. C. Briley-Saebo, V. Mani, G. Goldschlager, J. Machac, V. Fuster, and Z. A. Fayad
Detection of Neovessels in Atherosclerotic Plaques of Rabbits Using Dynamic Contrast Enhanced MRI and 18F-FDG PET
Arterioscler. Thromb. Vasc. Biol., July 1, 2008; 28(7): 1311 - 1317.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. C. Briley-Saebo, P. X. Shaw, W. J.M. Mulder, S.-H. Choi, E. Vucic, J. G. S. Aguinaldo, J. L. Witztum, V. Fuster, S. Tsimikas, and Z. A. Fayad
Targeted Molecular Probes for Imaging Atherosclerotic Lesions With Magnetic Resonance Using Antibodies That Recognize Oxidation-Specific Epitopes
Circulation, June 24, 2008; 117(25): 3206 - 3215.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. R. Vesely and V. Dilsizian
Nuclear Cardiac Stress Testing in the Era of Molecular Medicine
J. Nucl. Med., March 1, 2008; 49(3): 399 - 413.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. P. S. Dunphy, H. Schoder, and H. W. Strauss
Radionuclide Techniques for Identifying Vulnerable Plaque
J. Nucl. Med., November 1, 2007; 48(11): 1753 - 1755.
[Full Text] [PDF]


Home page
CirculationHome page
F. A. Jaffer, P. Libby, and R. Weissleder
Molecular Imaging of Cardiovascular Disease
Circulation, August 28, 2007; 116(9): 1052 - 1061.
[Full Text] [PDF]


Home page
JNMHome page
Y.-W. Wu, H.-L. Kao, M.-F. Chen, B.-C. Lee, W.-Y. I. Tseng, J.-S. Jeng, K.-Y. Tzen, R.-F. Yen, P.-J. Huang, and W.-S. Yang
Characterization of Plaques Using 18F-FDG PET/CT in Patients with Carotid Atherosclerosis and Correlation with Matrix Metalloproteinase-1
J. Nucl. Med., February 1, 2007; 48(2): 227 - 233.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement